Research study Program year 2025 Source: CMS Open Payments

Study of Ocrelizumab in PPMS Patients Assessing Upper Limb Function

Research payments

$1,411,189

573 payments

Through program year 2025, $1,411,189 in research payments was reported against Study of Ocrelizumab in PPMS Patients Assessing Upper Limb Function, across 573 payments.

Paid by (largest first): F. Hoffmann-La Roche AG; Hoffmann-La Roche Limited; Genentech, Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$209,564	80
2024	Research	$215,823	38
2023	Research	$258,370	74
2022	Research	$140,455	86
2021	Research	$267,241	152
2020	Research	$244,690	123
2019	Research	$75,046	20

Breakdown

Who paid Research payments · program years 2019–2025

F. Hoffmann-La Roche AG $1,097,948 391 payments
Hoffmann-La Roche Limited $310,540 180 payments
Genentech, Inc. $2,700 2 payments

Who received the money Research payments · program years 2019–2025

Langley Porter Psychiatric Hospital Teaching hospital · CA $365,820 7 payments
Geodyssey Research LLC Organisation paid for research $238,771 265 payments
Georgetown University Organisation paid for research $130,989 27 payments
Kumc Research Institute INC Organisation paid for research $95,416 31 payments
Neurological Services Of Orlando PA Organisation paid for research $74,069 28 payments
Ms Neuromuscular Center Of Excellence LLC Organisation paid for research $70,772 47 payments
Columbus Neuroscience LLC Organisation paid for research $64,829 13 payments
Honorhealth Scottsdale Shea Med Ctr Teaching hospital · AZ $44,951 16 payments
Wheaton Franciscan Healthcare Organisation paid for research $31,673 18 payments
Interspond Llc Organisation paid for research $31,000 7 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

5 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.